Minimally invasive surgical device company SI-Bone closed its initial public offering of 8.28 million shares of common stock in October.
Here are four insights:
1. The more than 8 million shares of common stock were priced at $15 per share to the public.
2. All offered by SI-Bone, the shares began trading on the NASDAQ global market Oct. 17.
3. In celebration of the shares going public, SI-Bone CEO and President Jeffrey Dunn rang the opening bell at the New York City-based NASDAQ MarketSite in Times Square Nov. 30.
4. SI-Bone created the iFuse Implant System, which is a minimally invasive surgical system designed to fuse the sacroiliac joint to treat sacroiliac joint dysfunction.